NEW YORK (GenomeWeb News) – Osmetech today said that Thermo Fisher Scientific division Fisher HealthCare will distribute its eSensor XT-8 instrument platform and molecular diagnostic tests and consumables in the US.

The distribution agreement has a term of five years. Financial and other details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.